Cargando…
A study of the use of carbamazepine, pregabalin and alpha lipoic acid in patients of diabetic neuropathy
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a common, symptomatic, long-term complication of diabetes mellitus. Many of the agents used to treat DN have not been compared with each other. This study was, therefore, undertaken to compare the efficacy and safety of carbamazepine, pregabalin an...
Autores principales: | Patel, Niral, Mishra, Vishal, Patel, Prakruti, Dikshit, Ram K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055259/ https://www.ncbi.nlm.nih.gov/pubmed/24926454 http://dx.doi.org/10.1186/2251-6581-13-62 |
Ejemplares similares
-
Effect of Alpha-Lipoic Acid in the Treatment of Diabetic Neuropathy: A Systematic Review
por: Abubaker, Saleh A, et al.
Publicado: (2022) -
Diabetes and Alpha Lipoic Acid
por: Golbidi, Saeid, et al.
Publicado: (2011) -
The Effect of Alpha-Lipoic Acid on Diabetic Peripheral Neuropathy and the Upcoming Depressive Disorders of Type II Diabetics
por: Karalis, Dimitrios T, et al.
Publicado: (2021) -
Combination of Alpha Lipoic Acid and Superoxide Dismutase Leads to Physiological and Symptomatic Improvements in Diabetic Neuropathy
por: Bertolotto, Fulvio, et al.
Publicado: (2012) -
Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
por: Wang, Xiaotong, et al.
Publicado: (2018)